The Fraunhofer-Gesellschaft, a leading German research organization, has announced a major open tender for the installation of cleanrooms as part of the Reinraumsystem project. This project aims to enhance high-tech research facilities in Dresden

The contract covers the design, installation, and commissioning of specialized cleanroom infrastructure, ensuring compliance with strict environmental and technical standards.

𝗞𝗲𝘆 𝗧𝗲𝗻𝗱𝗲𝗿 𝗗𝗲𝘁𝗮𝗶𝗹𝘀:

📌 Contracting Authority: Fraunhofer-Gesellschaft

📌 Project Location: Dresden, Germany 🇩🇪

📌 Project Duration: June 2, 2025 – December 19, 2025

📌 Submission Deadline: March 18, 2025, at 1:00 PM (UTC+1)

📌 Tender Type: Open Procedure

The global cleanroom technology market, valued at $6.9 billion in 2024, is projected to grow at a CAGR of 6.3% over the next five years, driven by rising demand in biotechnology, pharmaceuticals, semiconductor manufacturing, and advanced electronics. With industries requiring stricter contamination control, sustainable designs, and greater flexibility, cleanroom construction is undergoing a major transformation in 2025 and beyond.

Performance Contracting, Inc. highlights the most critical trends shaping the future of cleanroom construction, emphasizing modular solutions, energy efficiency, AI-driven automation, and hybrid models that streamline operations.

𝗞𝗲𝘆 𝗧𝗿𝗲𝗻𝗱𝘀 𝗦𝗵𝗮𝗽𝗶𝗻𝗴 𝗖𝗹𝗲𝗮𝗻𝗿𝗼𝗼𝗺 𝗖𝗼𝗻𝘀𝘁𝗿𝘂𝗰𝘁𝗶𝗼𝗻

✅ Modular & Prefabricated Cleanrooms – Faster deployment, scalability, and cost efficiency drive the adoption of modular systems. Prefabrication ensures better quality control and reduces contamination risks.

✅ Sustainability & Energy Efficiency – Cleanrooms are integrating energy recovery systems, LED lighting, and optimized HVAC solutions to cut energy consumption while maintaining strict cleanliness standards.

Roanoke officials are pushing for $5 million in state funding to build clean rooms in a new biotech incubator on South Jefferson Street. The site, a former Carilion Clinic building, is undergoing renovations to house shared lab space, expected to open by late 2025.

Governor Glenn Youngkin and the Virginia House of Delegates included the funding in their budget proposals, but the Senate removed it. Local leaders, including Roanoke Economic Development Director Marc Nelson, continue to advocate for its approval.

Clean rooms are vital for biotech manufacturing, especially for cell and gene therapy companies, a sector Roanoke hopes to attract. The city must secure an anchor tenant and match the funding to move forward. Meanwhile, a smaller modular clean room at Fralin Biomedical Research Institute, funded by GO Virginia and private investment, is set to open in March.

The final decision on state funding is expected by February 22 as lawmakers finalize the budget.

Orano Med is making a significant investment in France’s radiopharmaceutical sector with the construction of a €250 million Advanced Thorium Extraction Facility (ATEF) in Bessines-sur-Gartempe. This 7,000-square-meter site will produce thorium-228, a key precursor for lead-212-based radioligand therapies, which are used in targeted cancer treatments.

𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗣𝗿𝗼𝗷𝗲𝗰𝘁:

• Expected opening: 2027

• Capacity: Will increase lead-212 extraction tenfold, ensuring supply for clinical trials and commercial treatments

• Production Goal: 100,000 radiopharmaceutical doses per year within the next decade

• Job Creation: 70 direct jobs + 100 indirect employment opportunities

• Government Support: €22 million funding from the France 2030 program

This facility follows Orano Med’s recent expansion into the U.S., where it is building a radiopharma production plant in Brownsburg, Indiana (Alpha Therapy Laboratory - ATLab). Additionally, Orano Med has entered a €300 million radioligand partnership with Sanofi, which includes Sanofi taking a 16% equity stake in the venture.

ROTOP Pharmaka GmbH, a leading German manufacturer and CDMO specializing in radiopharmaceuticals, has secured a strategic investment from Genui and SHS Capital. This partnership is set to enhance ROTOP’s expertise in developing and producing innovative medical imaging and therapeutic solutions, reinforcing its role in the growing radiopharmaceutical market.

With this capital injection, ROTOP aims to expand its capabilities, drive innovation, and strengthen its market presence both in Germany and internationally. This investment highlights the increasing importance of radiopharmaceuticals in modern healthcare, particularly in diagnostics and targeted therapies.

Photo: rotop-pharmaka.de